Literature DB >> 30177246

Targeting volume overload and overnight rostral fluid shift: A new perspective to treat sleep apnea.

Elisa Perger1, Etienne-Marie Jutant2, Stefania Redolfi3.   

Abstract

Sleep apnea is a common condition associated with increased morbidity and mortality. Continuous positive airway pressure and oral appliances are efficient for treating sleep apnea; however, they are often poorly tolerated. Therefore, alternative therapies are needed. Overnight rostral fluid shift has been implicated in the pathogenesis of sleep apnea, particularly in conditions associated with fluid overload. Fluid shift predisposes to both obstructive and central sleep apnea, with the type of sleep apnea being related to whether the fluid shifts from the legs into the neck or chest, respectively. The amount of fluid that shifts from the legs to the upper part of the body at night is correlated with the severity of sleep apnea. As a result of this observation, it has been suggested that the prevention of overnight fluid shift may reduce sleep apnea severity. It has recently been shown that interventions targeting fluid overload and daytime fluid accumulation in the legs consistently attenuate nocturnal fluid shift and sleep apnea, as greater reductions in fluid shift are correlated with greater reductions in sleep apnea severity. This review will focus on interventions that counteract fluid shift, such as diuretics, ultrafiltration/dialysis, physical activity, compression stockings and salt/fluid restriction, which have been shown to have efficacy in reducing sleep apnea severity.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Central sleep apnea; Compression stockings; Diuretics; Obstructive sleep apnea; Overnight rostral fluid shift; Physical activity; Salt/fluid restriction treatment; Sleep apnea; Ultrafiltration

Mesh:

Year:  2018        PMID: 30177246     DOI: 10.1016/j.smrv.2018.07.008

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  6 in total

Review 1.  Obstructive Sleep Apnea and Adherence to Continuous Positive Airway Pressure (CPAP) Treatment: Let's Talk about Partners!

Authors:  Debora Rosa; Carla Amigoni; Elisa Rimoldi; Paola Ripa; Antonella Ligorio; Miriam Fracchiolla; Carolina Lombardi; Gianfranco Parati; Elisa Perger
Journal:  Healthcare (Basel)       Date:  2022-05-19

2.  Effects of inhaled fluticasone propionate on extrinsic tongue muscles in rats.

Authors:  Christopher Setzke; Oleg Broytman; John A Russell; Natalie Morel; Michelle Sonsalla; Dudley W Lamming; Nadine P Connor; Mihaela Teodorescu
Journal:  J Appl Physiol (1985)       Date:  2020-01-16

3.  Association between severity of obstructive sleep apnea and high-sensitivity C-reactive protein in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Juan Wang; Haobo Xu; Chao Guo; Xin Duan; Fenghuan Hu; Weixian Yang; Jingang Cui; Lei Song; Yushi Chun; Jiansong Yuan; Shubin Qiao
Journal:  Clin Cardiol       Date:  2020-05-27       Impact factor: 2.882

4.  Nocturnal thoracic volume overload and post-discharge outcomes in patients hospitalized for acute heart failure.

Authors:  Hao-Chih Chang; Chi-Jung Huang; Hao-Min Cheng; Wen-Chung Yu; Chern-En Chiang; Shih-Hsien Sung; Chen-Huan Chen
Journal:  ESC Heart Fail       Date:  2020-07-18

Review 5.  Obstructive Sleep Apnea and Cardiovascular Diseases: Sad Realities and Untold Truths regarding Care of Patients in 2022.

Authors:  Satya Preetham Gunta; Roopesh Sai Jakulla; Aamer Ubaid; Kareem Mohamed; Abid Bhat; Angel López-Candales; Nicholas Norgard
Journal:  Cardiovasc Ther       Date:  2022-08-11       Impact factor: 3.368

6.  Physical activity, sedentary behaviour and incidence of obstructive sleep apnoea in three prospective US cohorts.

Authors:  Yue Liu; Lin Yang; Meir J Stampfer; Susan Redline; Shelley S Tworoger; Tianyi Huang
Journal:  Eur Respir J       Date:  2022-02-03       Impact factor: 16.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.